NasdaqGS:FTRELife Sciences
Fortrea Holdings (FTRE) Is Up 7.6% After Raising 2025 Guidance and Surpassing Q3 Revenue Estimates
In November 2025, Fortrea Holdings raised its full-year 2025 revenue guidance to a range of US$2.7 billion to US$2.75 billion after reporting third-quarter revenues of US$701.3 million, which exceeded analyst expectations, despite a GAAP net loss of US$15.9 million for the quarter.
A unique aspect of the report was the company's significant improvement in win rates among biotech clients, coupled with a backlog of US$7.64 billion and a book-to-bill ratio of 1.13x, reflecting robust demand and...